19/09/2026
Funders’ engagements can be a real eye-opener. The recent PulaMed service provider meeting provided valuable insight into the pressures facing Botswana’s healthcare financing environment. One message that repeatedly stood out was Fraud, Waste and Abuse (FWA). These are not simply financial issues; when resources are lost through inappropriate or unnecessary healthcare utilisation, the consequences can ultimately affect funders, service providers, pharmacists and, most importantly, patients.
Five areas deserve particular attention in Botswana’s healthcare environment: unnecessary or duplicated investigations and services; inaccurate, inflated or inappropriate claims; inappropriate prescribing or dispensing of medicines; inadequate clinical documentation; and weaknesses in verification, authorisation and claims-management processes. Some FWA may be deliberate, while other cases can result from poor processes, misunderstanding of benefit rules or inadequate communication between healthcare providers and funders. The response therefore needs to address both behaviour and system weaknesses.
For healthcare service providers, implementation must start at facility level. Providers can strengthen pre-authorisation processes, conduct regular internal claims audits, reconcile services delivered against claims submitted, maintain complete clinical records and introduce routine staff training on funder rules and ethical billing. Healthcare facilities should also monitor unusual utilisation patterns and establish clear escalation procedures when discrepancies are identified. Prevention is considerably more sustainable than trying to recover losses after payment.
Pharmacists also have an important role in protecting the integrity of the healthcare financing system. Prescription verification, accurate dispensing records, appropriate quantity checks, monitoring of repeat and early-refill requests, and accurate submission of pharmacy claims should form part of everyday pharmacy governance. Where discrepancies arise, pharmacists should communicate with the prescriber and funder through appropriate channels rather than allowing questionable transactions to become routine. Good documentation remains one of the strongest safeguards for both the patient and the pharmacy.
The bigger conversation for Botswana is about sustainability and trust. Funders need effective controls, providers need workable and transparent processes, pharmacists need clear guidance, and patients need confidence that their healthcare benefits are being used appropriately. The fight against Fraud, Waste and Abuse should therefore not become a blame exercise it should be a collaborative healthcare-quality initiative.
Every p**a saved from unnecessary, inappropriate or fraudulent expenditure is a p**a that can potentially remain available for legitimate patient care.
